NO20000313L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20000313L
NO20000313L NO20000313A NO20000313A NO20000313L NO 20000313 L NO20000313 L NO 20000313L NO 20000313 A NO20000313 A NO 20000313A NO 20000313 A NO20000313 A NO 20000313A NO 20000313 L NO20000313 L NO 20000313L
Authority
NO
Norway
Prior art keywords
new connections
compounds
nhit
drugs
processes
Prior art date
Application number
NO20000313A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000313D0 (no
Inventor
Roger Brown
Garry Pairaudeau
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO20000313D0 publication Critical patent/NO20000313D0/no
Publication of NO20000313L publication Critical patent/NO20000313L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
NO20000313A 1997-07-22 2000-01-21 Nye forbindelser NO20000313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds
PCT/SE1998/001394 WO1999005144A1 (en) 1997-07-22 1998-07-15 Novel compounds

Publications (2)

Publication Number Publication Date
NO20000313D0 NO20000313D0 (no) 2000-01-21
NO20000313L true NO20000313L (no) 2000-03-22

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000313A NO20000313L (no) 1997-07-22 2000-01-21 Nye forbindelser

Country Status (21)

Country Link
US (1) US6166022A (ko)
EP (1) EP0998475B1 (ko)
JP (1) JP2001510843A (ko)
KR (1) KR20010022084A (ko)
CN (1) CN1270591A (ko)
AT (1) ATE216390T1 (ko)
AU (1) AU8370798A (ko)
BR (1) BR9811028A (ko)
CA (1) CA2296426A1 (ko)
DE (1) DE69804966T2 (ko)
EE (1) EE200000048A (ko)
HU (1) HUP0003826A3 (ko)
ID (1) ID25856A (ko)
IL (1) IL134111A0 (ko)
IS (1) IS5352A (ko)
NO (1) NO20000313L (ko)
PL (1) PL338181A1 (ko)
SE (1) SE9702774D0 (ko)
SK (1) SK188299A3 (ko)
TR (1) TR200000152T2 (ko)
WO (1) WO1999005144A1 (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
PL342430A1 (en) * 1998-02-17 2001-06-04 Astrazeneca Uk Ltd Novel compounds of triazolo[4,5-d]pyrimidine
AU753824B2 (en) * 1999-09-09 2002-10-31 Chirotech Technology Limited Substituted cyclopentenes, their preparation and their use for chiral scaffolds
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
MXPA06003625A (es) 2003-10-03 2006-08-11 Portola Pharm Inc Isoquinolinonas sustituidas.
KR20060113700A (ko) 2003-10-03 2006-11-02 포톨라 파마슈티컬스, 인코포레이티드 2,4-디옥소-3-퀴나졸리닐아릴 설포닐우레아
WO2005040174A1 (en) 2003-10-21 2005-05-06 Inspire Pharmaceuticals, Inc. Tetrahydro-furo`3,4-d!dioxole compounds and compositions and method for inhibiting platelet aggregation
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
CA2581638A1 (en) 2004-09-29 2006-04-13 Portola Pharmaceuticals, Inc. Substituted 2h-1,3-benzoxazin-4(3h)-ones
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JPWO2007020935A1 (ja) * 2005-08-17 2009-02-26 小野薬品工業株式会社 Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
KR101423483B1 (ko) 2005-11-03 2014-07-28 포톨라 파마슈티컬스, 인코포레이티드 〔４-(６-할로-７-치환된-２,４-디옥소-１,４-디히드로-２ｈ-퀴나졸린-３-일)-페닐〕-５-클로로티오펜-２-일-설포닐우레아 및 이의 형태 및 이와 관련된 방법
WO2008054795A2 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
WO2011133871A2 (en) * 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. 5'-end derivatives
WO2011150205A2 (en) * 2010-05-27 2011-12-01 Dr. Reddy's Laboratories Ltd. Highly selective asymmetric hydroformylation of (1s,4r) or (1r,4s)-2-azabicyclo[2.2.1]hept-5-en-3- one (+) or (-)-lactam
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
JPH08506343A (ja) * 1993-02-03 1996-07-09 ジェンシア・インコーポレイテッド リキソフラノシル誘導体を含むアデノシンキナーゼ阻害物質
CZ297200B6 (cs) * 1995-07-11 2006-09-13 Astrazeneca Ab Nové inhibitory agregace krevních desticek

Also Published As

Publication number Publication date
ID25856A (id) 2000-11-09
IL134111A0 (en) 2001-04-30
DE69804966T2 (de) 2002-11-07
WO1999005144A1 (en) 1999-02-04
AU8370798A (en) 1999-02-16
EP0998475A1 (en) 2000-05-10
CA2296426A1 (en) 1999-02-04
HUP0003826A2 (hu) 2001-04-28
DE69804966D1 (de) 2002-05-23
EE200000048A (et) 2000-10-16
US6166022A (en) 2000-12-26
KR20010022084A (ko) 2001-03-15
NO20000313D0 (no) 2000-01-21
EP0998475B1 (en) 2002-04-17
JP2001510843A (ja) 2001-08-07
IS5352A (is) 2000-01-19
TR200000152T2 (tr) 2000-07-21
BR9811028A (pt) 2000-08-01
SK188299A3 (en) 2000-08-14
HUP0003826A3 (en) 2001-11-28
SE9702774D0 (sv) 1997-07-22
CN1270591A (zh) 2000-10-18
ATE216390T1 (de) 2002-05-15
PL338181A1 (en) 2000-10-09

Similar Documents

Publication Publication Date Title
NO20000311L (no) Nye forbindelser
NO20000313L (no) Nye forbindelser
NO995006L (no) Nye forbindelser
TR200000197T2 (tr) Yeni bileşimler
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
NO993027L (no) Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler
ATE215954T1 (de) Pyrazolo(4,3-d)pyrimidin-derivate und diese enthaltende pharmazeutische zubereitungen
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
AU3799789A (en) Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
NO20004089L (no) Nye triazolo(4,5-d)pyrimidinforbindelser
TR199800585T2 (xx) COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar.
DK0624595T3 (da) Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
CA2338600A1 (en) Novel thiazolopyrimidine compounds
SE9904129D0 (sv) Novel compounds
SE9804212D0 (sv) Compounds
SE9802574D0 (sv) Novel compounds
ATE213241T1 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
SE9904128D0 (sv) Novel compounds
IL89538A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
AU1444695A (en) N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
ATE23719T1 (de) Rifamycinderivate, herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE272642T1 (de) Thieno(2,3-d)pyrimidindione und ihre verwendung als pharmazeutische mittel
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
BR0114734A (pt) 3,4-dihidropirido [1, 2-a] pirimidinas substituìdas
AU3138489A (en) Peptides with pharmaceutical activity

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application